STOCK TITAN

Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
Leixir Dental Laboratory Group (Leixir) (NASDAQ: LDXR) appoints John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries, succeeding founder Harmeet Bindra who continues as Executive Chairman. The appointment aims to drive operational excellence and expand Leixir's customer base, DSO relationships, and service offerings to support best-in-class dental patient care.
Positive
  • None.
Negative
  • None.

TAMPA, Fla.--(BUSINESS WIRE)-- Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman.

Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ: DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven years at Breg, Inc. Prior to that, Mr. Krier was President of Viscent, LLC. He began his career at Deloitte, where he served in a variety of client servicing positions over eight years with the firm.

“We are delighted to welcome John to Leixir,” said Mr. Bindra. “His wealth of multidisciplinary experience spans operations, new product launches, strategic acquisitions, customer-focused strategies, and team development. With a long track record of developing values-based company culture and driving operational excellence, John is well-suited to lead Leixir in its next phase of expansion.”

“John’s impressive leadership record, entrepreneurial mindset and healthcare experience will serve Leixir well in our ongoing commitment to providing industry leading service to dental service organizations (DSOs) as well as independent dentists,” said Marshall Griffin, a member of Leixir’s Board of Directors and a Partner of Comvest Partners, a private equity firm.

Said Mr. Krier: "I am honored for the opportunity to work alongside Leixir’s terrific leadership team and employees at such an exciting time. Leixir is well-positioned for strong continued growth as a dental lab provider of choice. I look forward to continuing to expand Leixir’s customer base, advance its DSO relationships and grow its service offering in support of best-in-class dental patient care.”

About Leixir Dental Laboratory Group

Leixir operates a network of full-service, state-of-the-art dental laboratories that offer a complete range of leading-edge dental products, including crowns and bridges, implants, surgical guides, and dentures. Leixir’s laboratories are strategically located to provide superior service to dentists throughout the United States. Leixir has built a digital-first service model to support its delivery of differentiated services and technology throughout the dental landscape. For more information, please visit www.leixir.com.

Sarah Tanatra

Marketing Manager

Leixir Dental Laboratory Group

sarah.tanatra@leixir.com

Source: Leixir Dental Laboratory Group

FAQ

Who is the new Chief Executive Officer of Leixir Dental Laboratory Group?

John Krier has been appointed as the new Chief Executive Officer of Leixir Dental Laboratory Group.

When will John Krier assume the role of Chief Executive Officer at Leixir Dental Laboratory Group?

John Krier will assume the role of Chief Executive Officer at Leixir Dental Laboratory Group effective January 2nd, 2024.

What is the ticker symbol of Leixir Dental Laboratory Group?

The ticker symbol of Leixir Dental Laboratory Group is LDXR.

What is the goal of the appointment of John Krier as the new CEO of Leixir Dental Laboratory Group?

The appointment aims to drive operational excellence and expand Leixir's customer base, DSO relationships, and service offerings to support best-in-class dental patient care.

DYNATRONICS CORP

OTC:DYNT

DYNT Rankings

DYNT Latest News

DYNT Stock Data

1.01M
4.11M
43.29%
0.35%
0.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SALT LAKE CITY